Lawrence Man Pleads Guilty To Conspiring To Manufacture And Distribute Counterfeit Pills
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Emerging Drug Trends
    • Illegal Online Pharmacies
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Emerging Drug Trends
    • Illegal Online Pharmacies
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Lawrence Man Pleads Guilty To Conspiring To Manufacture And Distribute Counterfeit Pills

Lawrence Man Pleads Guilty To Conspiring To Manufacture And Distribute Counterfeit Pills

Octubre 06, 2026
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kristen Govostes
Phone Number: (617) 557-2100

Defendant was a member of a drug trafficking organization known as “La Culebra”

BOSTON – A Lawrence man has pleaded guilty in federal court in Boston for his involvement in a drug manufacturing ring. Over two kilograms of suspected controlled substances and a pill press were recovered during related search warrants.

Aris Arvelo Gonzalez, 37, pleaded guilty to one count of conspiracy to manufacture, distribute and possess with intent to distribute and manufacture controlled substances. U.S. Senior District Court Judge Patti B. Saris scheduled sentencing for Jan. 13, 2027. Gonzalez was arrested and charged in November 2026.  

According to the charging documents, Gonzalez and La Culebra controlled a large drug manufacturing location inside an apartment in Methuen. During a search of the Methuen apartment in August 2025, over 18 kilograms of controlled substances and a pill press were recovered. 

While on pretrial release following a January 2025 arrest for drug offenses in Salem District Court in New Hampshire, Gonzalez sold over 1,500 grams of counterfeit pills containing fentanyl to a confidential informant and an undercover agent on four occasions between July 2025 and November 2025. 

At the time of Gonzalez’s arrest, he was found in possession of thousands of counterfeit pills bundled into smaller bags as well as a large quantity of cash.

Following his arrest, search warrants were executed at three locations in Lawrence that were tied to Gonzalez and the La Culebra drug trafficking organization. During those searches, various items and materials used in the manufacturing of counterfeit Percocet containing fentanyl were recovered – including a pill press and a 25-kilogram bag of pill binding agent. 

The charge of conspiracy to manufacture, distribute and possess with intent to distribute or manufacture provides for sentence of up to 20 years in prison, at least three years and up to a lifetime of supervised release and a fine of up to $1 million. The charge of manufacturing and possessing a controlled substance with intent to distribute or manufacture provides for a sentence of up to 20 years in prison, at least three years and up to a lifetime of supervised release and a fine of up to $1 million. Sentences are imposed by a federal district court judge based upon the U.S. Sentencing Guidelines and statutes which govern the determination of a sentence in a criminal case.

United States Attorney Leah B. Foley; Ted E. Docks, Special Agent in Charge of the Federal Bureau of Investigation, Boston Division; Jarod A. Forget, Special Agent in Charge of the Drug Enforcement Administration in New England; and Colonel Geoffrey D. Noble, Superintendent of the Massachusetts State Police made the announcement today. Valuable assistance was provided by the Essex County District Attorney’s Office. Assistant U.S. Attorney Philip A. Mallard of the Organized Crime & Gang Unit is prosecuting the case.

This case is part of Operation Take Back America, a nationwide initiative that marshals the full resources of the Department of Justice to repel the invasion of illegal immigration, achieve the total elimination of cartels and transnational criminal organizations and protect our communities from the perpetrators of violent crime. Operation Take Back America streamlines efforts and resources from the Department’s Organized Crime Drug Enforcement Task Forces and Project Safe Neighborhood.

Download Press Release
###
Fentanyl
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Jarod Forget Special Agent in Charge - New England
@DEANewEngland
  • Facebook
  • X
  • linkedin
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster